Molecular Partners AG -ADRMOLN
13F holders, Q2 2025 (June 30)6holders
1new positions
1sold out
$3.82avg. 13F price*
At the end of Q2 2025, 6 institutions reported holding Molecular Partners AG -ADR (MOLN) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were Montanova Capital, LLC ($8.5M), BVF Inc. ($5.2M) and UBS Group AG ($39K).
- Company
- Molecular Partners AG -ADR
- CUSIP
- 60853G106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $157 |
| Exits | 1 | $1K |
All 13F filers, Q1 2025 → Q2 2025: 3,889 shares bought and 269 shares sold, net +3,620 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Montanova Capital, LLC | 0.32% | No change | 2,221,494 | $8.5M |
| BVF Inc. | 0.19% | No change | 1,353,968 | $5.2M |
| UBS Group AG | 0.00% | Add +60.6% | 10,199 | $39K |
| Morgan Stanley | 0.00% | No change | 367 | $1K |
| Bank of America Corp. | 0.00% | No change | 157 | $600 |
| EverSource Wealth Advisors, LLC | 0.00% | New | 41 | $157 |
"% of holder's portfolio" is MOLN's weight in each manager's 13F, not the share of Molecular Partners AG -ADR the manager owns.